Skip to main content

What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?

Abstract

Background: There are limited data on what is the minimum change that can be detected in cancer patients undergoing treatment with cardiotoxic drugs and are referred for monitoring left ventricular (LV) function.

Objective: To assess the variability in the measurement of LV volumes and ejection fraction (EF) in contrast echocardiography and to determine the minimum detectable difference (MDD) between two EF measurements that can be deemed significant.

Methods: A total of 150 patients were divided into three groups according to EF (EF <53, 53–60, and >60%). Each group consisted of 50 randomly selected cancer patients who underwent contrast echocardiography between July 2010 and May 2014. Repeated measurements of LV volumes and EF were performed offline by a sonographer and a cardiologist. Inter-observer variability was assessed by analysis of variance. Measurement error was estimated by standard error of measurement and MDD.

Results: The 95% confidence interval with a single measurement of EF was 2 percentage points in the groups of patients with EF <53% and EF >60%, and 2.5 percentage points for patients with EF 53–60%. The MDD for EF, end-diastolic volume and end-systolic volume that could be recognized with 95% confidence interval were 4 percentage points, 7 mL and 4 mL, respectively.

Conclusion: Contrast echocardiography is a reliable tool for serial measurements of EF to monitor cardiotoxicity due to chemotherapy. In a high-volume echocardiography laboratory with experienced staff, the MDD for EF of 4 percentage points on a good-quality recording demonstrates the high reproducibility of the Simpson’s method using contrast echocardiography.

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. Journal of the American College of Cardiology 2014 63 e57–e185. (https://doi.org/10.1016/j.jacc.2014.02.536)

    Article  Google Scholar 

  2. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA Guideline for management of heart failure. Journal of the American College of Cardiology 2013 62 e147–e239. (https://doi.org/10.1016/j.jacc.2013.05.019)

    Article  Google Scholar 

  3. Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction. Circulation: Heart Failure 2016 9 e002962. (https://doi.org/10.1161/CIRCHEARTFAILURE.115.002962)

    Google Scholar 

  4. Nijland F, Kamp O, Verhorst PM, de Voogt WG, Visser CA. Early prediction of improvement in ejection fraction after acute myocardial infraction using low dose dobutamine echocardiography. Heart 2002 88 592–596. (https://doi.org/10.1136/heart.88.6.592)

    Article  CAS  Google Scholar 

  5. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P, Edvardsen T, Lancellotti P, EACVI Scientific Documents Committee for 2014-16 and 2016-18, et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. European Heart Journal: Cardiovascular Imaging 2017 18 1205–af. (https://doi.org/10.1093/ehjci/jex182)

    PubMed  Google Scholar 

  6. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, Ganame J, Sebag IA, Agler DA, Badano LP, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 2014 27 911–939. (https://doi.org/10.1016/j.echo.2014.07.012)

    Article  Google Scholar 

  7. Becher H, Gibson PH. Contrast echocardiography: current applications and future perspectives. Current Cardiovascular Imaging Reports 2013 6 473–485. (https://doi.org/10.1007/s12410-013-9234-0)

    Article  Google Scholar 

  8. Larsson MK, Da Silva C, Gunyeli E, Ilami AA, Szummer K, Winter R, Bjällmark A. The potential clinical value of contrast-enhanced echocardiography beyond current recommendations. Cardiovascular Ultrasound 2016 14 2. (https://doi.org/10.1186/s12947-015-0045-0)

    Article  Google Scholar 

  9. Tang A, Chiew SK, Rashkovetsky R, Becher H, Choy JB. Feasibility of sonographer-administered echocontrast in a large-volume tertiary-care echocardiography laboratory. Canadian Journal of Cardiology 2013 29 391–395. (https://doi.org/10.1016/j.cjca.2012.07.008)

    Article  Google Scholar 

  10. Porter TR, Abdelmoneim S, Belcik T, McCulloch ML, Mulvagh SL, Olson JJ, Porcelli C, Tsutsui JM, Wei K. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. Journal of the American Society of Echocardiography 2014 27 797–810. (https://doi.org/10.1016/j.echo.2014.05.011)

    Article  Google Scholar 

  11. Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. Journal of the American Society of Echocardiography 2015 28 1171–1181. (https://doi.org/10.1016/j.echo.2015.06.011)

    Article  Google Scholar 

  12. Popovic ZB, Thomas JD. Assessing observer variability: a user’s guide. Cardiovascular Diagnosis and Therapy 2017 3 317–324. (https://doi.org/10.21037/cdt.2017.03.12)

    Article  Google Scholar 

  13. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. Journal of the American College of Cardiology 2013 61 77–84. (https://doi.org/10.1016/j.jacc.2012.09.035)

    Article  Google Scholar 

  14. Moody WE, Edwards NC, Chue CD, Taylor RJ, Ferro CJ, Townend JN, Steeds RP. Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year. British Journal of Radiology 2015 88 20140831. (https://doi.org/10.1259/bjr.20140831)

    Article  CAS  Google Scholar 

  15. Kleijn SA, Aly MF, Terwee CB, van Rossum AC, Kamp O. Reliability of left ventricular volumes and function measurements using three-dimensional speckle tracking echocardiography. European Heart Journal: Cardiovascular Imaging 2012 13 159–168. (https://doi.org/10.1093/ejechocard/jer174)

    PubMed  Google Scholar 

  16. Bland JM. How can I decide the sample size for a repeatability study? University of York, UK: Bland JM, 2010. (available at: https://www-users.york.ac.uk/~mb55/meas/sizerep.htm)

    Google Scholar 

  17. Otterstad JE, Froeland G, St John Sutton M, Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. European Heart Journal 1997 18 507–513. (https://doi.org/10.1093/oxfordjournals.eurheartj.a015273)

    Article  CAS  Google Scholar 

  18. Nayyar S, Magalski A, Khumri TM, Idupulapati M, Stoner CN, Kusnetzky LL, Coggins TR, Morris BA, Main ML. Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline endocardial border delineation. American Journal of Cardiology 2006 98 1110–1114. (https://doi.org/10.1016/j.amjcard.2006.05.038)

    Article  CAS  Google Scholar 

  19. He W, Leung E, Chiew S, Pituskin E, Paterson I, Choy JB, Becher H. Contrast echocardiography for monitoring cardiotoxic effects of chemotherapy: quality control in clinical practice with sonographer administered contrast. Journal of the American Society of Echocardiography 2013 26 abstract P1-105 B39–B40. (https://doi.org/10.1016/j.echo.2013.04.002)

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harald Becher MD PhD.

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suwatanaviroj, T., He, W., Pituskin, E. et al. What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?. Echo Res Pract 5, 71–77 (2018). https://doi.org/10.1530/ERP-18-0003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-18-0003

Key Words